• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌的化学预防:当前视角与未来方向。

Chemoprevention in Prostate Cancer: Current Perspective and Future Directions.

机构信息

Department of Urology, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229.

Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229.

出版信息

Cold Spring Harb Perspect Med. 2018 Oct 1;8(10):a030494. doi: 10.1101/cshperspect.a030494.

DOI:10.1101/cshperspect.a030494
PMID:29311128
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6169981/
Abstract

Chemoprevention of prostate cancer aims to reduce the mortality as well as the public burden of overdetection, which increases anxiety, cost, and morbidity related to the disease. The role of 5-α-reductase inhibitors has been well investigated and shown to decrease the risk of prostate cancer. No current evidence exists to encourage the use of nutrients or vitamins as chemopreventive agents. The modulation of inflammation is one of the most promising targets for chemoprevention of prostate cancer.

摘要

前列腺癌的化学预防旨在降低过度检测导致的死亡率和公共负担,过度检测会增加疾病相关的焦虑、成本和发病率。5-α-还原酶抑制剂的作用已得到充分研究,已证明其可降低前列腺癌的风险。目前尚无证据表明鼓励使用营养物或维生素作为化学预防剂。炎症的调节是前列腺癌化学预防最有前途的靶点之一。

相似文献

1
Chemoprevention in Prostate Cancer: Current Perspective and Future Directions.前列腺癌的化学预防:当前视角与未来方向。
Cold Spring Harb Perspect Med. 2018 Oct 1;8(10):a030494. doi: 10.1101/cshperspect.a030494.
2
[Role of 5 alpha-reductase inhibitors in the chemoprevention of prostate cancer].5α-还原酶抑制剂在前列腺癌化学预防中的作用
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2011 Oct;33(5):582-6.
3
Chemoprevention in prostate cancer: identifying patients at greatest risk may provide greatest value.前列腺癌的化学预防:识别风险最高的患者可能会带来最大价值。
Am J Manag Care. 2013 Mar-Apr;19 Spec No. 3:E8.
4
Chemoprevention of prostate cancer: myths and realities.前列腺癌的化学预防:神话与现实。
J Am Board Fam Med. 2012 Jan-Feb;25(1):111-9. doi: 10.3122/jabfm.2012.01.110117.
5
Prostate cancer chemoprevention with 5α-reductase inhibitors.5α-还原酶抑制剂用于前列腺癌化学预防
Urol Oncol. 2012 Sep;30(5):553-4. doi: 10.1016/j.urolonc.2011.02.006.
6
The use of 5-alpha reductase inhibitors for the prevention of prostate cancer.5-α 还原酶抑制剂在前列腺癌预防中的应用。
Cancer Biol Ther. 2010 Jul 1;10(1):11-2. doi: 10.4161/cbt.10.1.12368. Epub 2010 Jul 13.
7
Risk adapted chemoprevention for prostate cancer: an option?前列腺癌的风险适应性化学预防:一种选择?
Recent Results Cancer Res. 2014;202:79-91. doi: 10.1007/978-3-642-45195-9_10.
8
Revisiting 5α-reductase inhibitors and the risk of prostate cancer.重新审视 5α-还原酶抑制剂与前列腺癌风险。
Nat Rev Urol. 2018 Jul;15(7):400-401. doi: 10.1038/s41585-018-0018-9.
9
Prostate cancer chemoprevention.前列腺癌化学预防。
Semin Oncol. 2013 Jun;40(3):276-85. doi: 10.1053/j.seminoncol.2013.04.003.
10
Chemoprevention of prostate cancer: an updated view.前列腺癌的化学预防:更新的观点。
World J Urol. 2012 Apr;30(2):189-94. doi: 10.1007/s00345-011-0822-9. Epub 2012 Jan 12.

引用本文的文献

1
Main Inflammatory Cells and Potentials of Anti-Inflammatory Agents in Prostate Cancer.前列腺癌中的主要炎症细胞及抗炎药物的潜力
Cancers (Basel). 2019 Aug 12;11(8):1153. doi: 10.3390/cancers11081153.
2
Anti-Cancer Effects of Green Tea Polyphenols Against Prostate Cancer.绿茶多酚对前列腺癌的抗癌作用。
Molecules. 2019 Jan 7;24(1):193. doi: 10.3390/molecules24010193.

本文引用的文献

1
Statin use and mortality of patients with prostate cancer: a meta-analysis.他汀类药物的使用与前列腺癌患者的死亡率:一项荟萃分析。
Onco Targets Ther. 2016 Mar 21;9:1689-96. doi: 10.2147/OTT.S97993. eCollection 2016.
2
Cancer statistics, 2016.癌症统计数据,2016 年。
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30. doi: 10.3322/caac.21332. Epub 2016 Jan 7.
3
Molecular pathways and targets in prostate cancer.前列腺癌中的分子途径与靶点
Oncotarget. 2014 Sep 15;5(17):7217-59. doi: 10.18632/oncotarget.2406.
4
Prevention of prostate cancer: outcomes of clinical trials and future opportunities.前列腺癌的预防:临床试验结果与未来机遇
Am Soc Clin Oncol Educ Book. 2014:e76-80. doi: 10.14694/EdBook_AM.2014.34.e76.
5
Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial.在前列腺癌预防试验的安慰剂组中,良性前列腺组织中的慢性炎症与高级别前列腺癌相关。
Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):847-56. doi: 10.1158/1055-9965.EPI-13-1126. Epub 2014 Apr 18.
6
Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer risk.基础硒状态和硒与维生素 E 补充对前列腺癌风险的影响。
J Natl Cancer Inst. 2014 Mar;106(3):djt456. doi: 10.1093/jnci/djt456. Epub 2014 Feb 22.
7
Dietary lycopene, angiogenesis, and prostate cancer: a prospective study in the prostate-specific antigen era.膳食番茄红素、血管生成与前列腺癌:前列腺特异性抗原时代的前瞻性研究。
J Natl Cancer Inst. 2014 Feb;106(2):djt430. doi: 10.1093/jnci/djt430. Epub 2014 Jan 24.
8
Baseline prostate inflammation is associated with a reduced risk of prostate cancer in men undergoing repeat prostate biopsy: results from the REDUCE study.基线前列腺炎症与接受重复前列腺活检的男性前列腺癌风险降低相关:来自 REDUCE 研究的结果。
Cancer. 2014 Jan 15;120(2):190-6. doi: 10.1002/cncr.28349. Epub 2013 Dec 9.
9
Soy and soy isoflavones in prostate cancer: a systematic review and meta-analysis of randomized controlled trials.大豆及其异黄酮与前列腺癌:一项随机对照试验的系统评价和荟萃分析。
BJU Int. 2014 May;113(5b):E119-30. doi: 10.1111/bju.12435.
10
Long-term survival of participants in the prostate cancer prevention trial.前列腺癌预防试验参与者的长期生存情况。
N Engl J Med. 2013 Aug 15;369(7):603-10. doi: 10.1056/NEJMoa1215932.